New Zealand markets open in 1 hour 26 minutes

BIOR Sep 2022 3.000 put(CONTRAC

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.20000.0000 (0.00%)
As of 12:02PM EDT. Market open.
Full screen
Previous close2.2000
Open2.2000
Bid2.2400
Ask2.4300
Strike3.00
Expiry date2022-09-16
Day's range2.2000 - 2.2000
Contract rangeN/A
Volume10
Open interest125
  • GlobeNewswire

    Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference

    SAN DIEGO, June 22, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of an abstract presenting data on the autonomous triggering and injection efficiency of its systemic therapeutics delivery system by the Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference. This meeting explores the latest technological advances in the drug delivery devices arena a

  • GlobeNewswire

    Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis

    Oral Presentation Delivered at DDW 2022 Informs Clinical Study Design for Biora’s Targeted Therapeutics PlatformSAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a presentation delivered during Digestive Disease Week® (DDW), May 21-24, 2022 in San Diego. DDW is the world’s premier meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gast

  • GlobeNewswire

    Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022

    Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof of Concept for Microbiome Sampling Capsule SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared two posters that were presented during the Digestive Disease Week® (DDW), May 21-24, 2022 in San Diego. DDW is the world’s premier meeti